6990 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. engages in the research and development, manufacture, and commercialization of novel drugs. It offers proprietary technology platforms focusing on the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancers, and colorectal cancer, as well as non-oncology diseases. The company was founded by Ge Xin Liu on November 22, 2016 and is headquartered in Chengdu, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6990 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company